Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shanghai's Brii Bio Invests in Artizan; Gains China Rights to Microbiota Treatment for IBD

publication date: Jun 11, 2019

Shanghai's Brii Bioscience will have China rights to as many as three infectious disease candidates developed by Artizan Biosciences, a spin-out from Yale University. Brii participated in a Series A funding that brought Artizan's total funds raised to $12 million, though Brii's financial commitment to the round was not disclosed. Artizan is developing intestinal microbiota candidates for inflammatory diseases including its lead candidate, a treatment for Inflammatory Bowel Disease (IBD). Artizan uses its IgA-SEQ™ technology platform to identify disease-driving bacteria contained in human intestinal microbiota. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here